Adani Enterprises is currently trading at Rs 2355.90, reflecting a slight increase of 0.22% today, despite a challenging one-year return of -17.19%. Adani Enterprises is trading at Rs 2359.0, showing ...

On Mar 3, we issued an updated research report on Intersect ENT, Inc. XENT. While the company’s bright long-term prospects, driven by the favorable Chronic Sinusitis market encourage us, its choppy ...

According to a recent report by Market.us, the Global ENT Devices Market size is expected to be worth around USD 42.7 Billion by 2033 from USD 23.2 Billion in 2023, growing at a CAGR of 6.3% during ...

Sinus problems can be a persistent source of frustration and discomfort. These issues can significantly impact your daily life, from facial pressure and headaches to congestion and a relentless drip.

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced the appointment of Mark L. Alley as Vice ...

According to Fact MR’s recent market research, sales of ENT Devices to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of ...

PRESQUE ISLE, Maine (WAGM) - Ear infections, tonsil issues, and allergies are among the most common reasons children see an Ear, Nose, and Throat specialist. In this week’s Medical Monday, Brian ...

Adani Enterprises plans to raise Rs 25,000 crore via a rights issue to fund expansion in renewable energy and airports Adani Enterprises is currently valued at Rs 2423.70, reflecting a decrease of ...